Ai-acellerated Structure-based Discovery of Y4 Receptor Antagonists as Glp-1 and Amylin Receptor Agonist-enhancing Anti-obesity Drugs
Funder: Novo Nordisk Fonden
Amount: DKK 1,100,000
Funding type: research
Funder scheme: Pioneer Innovator
Start date: 2024-01-01
Investigator: Thue W. Schwartz
Institution: University of Copenhagen
Funded outputs count: 0
Funder award ID: nnf-grant-dfb1cec97e5b6797
OpenAlex ID: G5114713377